BUSINESS
Indian pharma market grows 9.4% in 2018 led by medicines for chronic diseases
The growth was aided by sales of cardiac and anti-diabetes medications whose sales grew 11.7 percent to Rs 16,021 crore and 12.9 percent to Rs 12,143 respectively on YoY basis.
BUSINESS
German specialty chemicals maker Evonik bets big on India with evolving environmental standards
Sanjeev Taneja, President and Managing Director of Evonik India says there is much more room for the business to grow led by ever growing middle class and fast paced urbanization, and demand for cleaner, greener and more sustainable products.
BUSINESS
Shalby Hospitals in talks to take control of two hospitals in Delhi, Kolkata for Rs 250 crore
The Delhi hospital has a 150 bed capacity, while Kolkata is a 200 bedded hospital.
BUSINESS
J&J hip implant case: Time to get serious about having robust national clinical registries
It is estimated that close to two lakh knee replacements and 30,000-40,000 hip replacements are done in India, annually. However, the ISHKS registry only received data related to 30,000 surgeries in 2017
BUSINESS
NephroPlus to raise Rs 150 crore for international expansion
So far the company raised Rs 200 crore funding from investors such as International Finance Corporation, SeaLink Capital Partners and Bessemer Venture Capital.
BUSINESS
Private healthcare players welcome government sops to set up hospitals
“At the current package rates offered under Ayushman Bharat, it is not viable to put up hospitals in these places, viability gap funding (VGF) and cross-subsidisation are the way to go,” said Ranjan Pai of Manipal Hospitals.
BUSINESS
J&J faulty hip implants case: Expert committee seeks more time to work on compensation
Nearly 40 victims and their family members have met with the Central Expert Committee to share their concerns regarding the health issues faced by them, compensation formula, the process and related issues with the Committee.
BUSINESS
Government lures private sector with land and funding sops to set up hospitals in tier 2 and 3 cities
The private sector will build, design, finance, manage, operate and maintain with quality standards. Take market risk and provide services at PMJAY rates.
BUSINESS
Pfizer to shutdown Chennai, Aurangabad plants, may impact 1700 employees
Both plants came under Pfizer's ownership after it acquired Hospira in the US.
BUSINESS
Lawmakers urge govt action against J&J in faulty hip implant case
There are currently no specific legal provisions to provide compensation to patients.
BUSINESS
The Bedaquiline conundrum: Why this TB drug is creating an intense debate
Bedaquiline, developed by Johnson & Johnson (J&J), is used for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB)
BUSINESS
Valsartan recalls raise blood pressure of Indian drug makers
So far US FDA inspectors believe contaminated compounds were unintentionally created through a chemical reaction.
ECONOMY
Ayushman Bharat's implementing agency gets full autonomy
“The National Health Authority shall have full autonomy, accountability and the mandate to implement PM-JAY through an efficient, effective and transparent decision-making process,” the government said in statement.
BUSINESS
NBFC sector remains fragile, but seeing signs of recovery: Uday Kotak
"The NBFC sector, which saw significant pressure in October-November, is beginning to breathe a little better," he said in an annual message to employees of Kotak Mahindra Bank.
BUSINESS
100 days of Ayushman Bharat: 6.85 lakh patients availed free treatment, 5,000 claims handled daily
So far 6.85 lakh patients have been provided free hospital treatment under the scheme. Around 5.1 lakh claims have been availed of the scheme, for which payment has been released.
BUSINESS
Govt sets up council to boost local manufacturing, export of medical devices
The Council will be headed by Secretary, DIPP of the Ministry of Commerce and Industry
BUSINESS
A look at how Cipla is trying to consolidate its position in respiratory segment
Cipla sells a range of products including pills, nasal sprays and inhalers to treat respiratory diseases.
BUSINESS
Rising shipments to US help Indian pharma exports rebound in H1FY19
In the first half of FY19, shipments to US rose 10.34 percent to $3.2 billion, while exports to other countries grew 13 percent to $7.6 billion.
BUSINESS
Major factors that moved the pharma and healthcare industries in 2018; what to expect in 2019
The sectors didn't bring much cheer to investors and the S&P BSE Healthcare index that represents pharma and healthcare stocks underperformed compared to the benchmark Sensex.
BUSINESS
Operational, regulatory challenges hasten consolidation in Indian private hospital sector
Analysts tracking the sector say hospital businesses have been witnessing deterioration since the beginning of 2017.
BUSINESS
Max India to sell stake in Max Healthcare to Radiant, KKR
The deal includes Radiant Life's purchase of a 49.7 percent stake in Max Healthcare from South Africa-based hospital operator Life Healthcare International Proprietary.
BUSINESS
Lupin out-licenses novel blood cancer drug to AbbVie
Under the terms of the agreement, AbbVie will pay Lupin an upfront payment of $30 million for an exclusive license to the program.
BUSINESS
Biocon-Mylan faces competition in US for trastuzumab from Teva-Celltrion duo
It's not just Mylan-Biocon and Celltrion-Teva, other rival drug makers such as Samsung Bioepis, Pfizer and Amgen have all coming-up with their trastuzumab versions, indicating intensified competition for the drug that raked in about $7.55 billion of sales in 2017.
BUSINESS
Merger of GSK-Pfizer consumer businesses may not have much impact in India
At least three popular brands of Pfizer in India, Corex, Gelusil, Becosules will be not be marketed under that JV. Those three key brands constitute about one-fifth of Pfizer's sales in India.
